Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosa Macamo"'
Autor:
Raquel Matavele Chissumba, Cacildo Magul, Rosa Macamo, Vânia Monteiro, Maria Enosse, Ivalda Macicame, Victória Cumbane, Nilesh Bhatt, Edna Viegas, Michelle Imbach, Leigh Anne Eller, Christina S. Polyak, Luc Kestens, for the RV363 Study Group
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Human immunodeficiency virus type 1 (HIV-1) causes impairment of T and B cell responses, which begins during the acute phase of infection and is not completely restored by antiretroviral treatment. Regulatory T cell (Tregs) can im
Externí odkaz:
https://doaj.org/article/46635a86ed3e441ea10b159604acf482
Autor:
Nádia Sitoe, Rosa Macamo, Bindiya Meggi, Ocean Tobaiwa, Osvaldo Loquiha, Timothy Bollinger, Lara Vojnov, Ilesh Jani
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165163 (2016)
In resource-limited countries, CD4 T-cell (CD4) testing continues to be used for determining antiretroviral therapy (ART) initiation eligibility and opportunistic infection monitoring. To support expanded access to CD4 testing, simple and robust tech
Externí odkaz:
https://doaj.org/article/c912a4420a244dbcad67dca75539b932
Autor:
Luc Kestens, Nilesh Bhatt, Ilesh V. Jani, Edna Viegas, Rosa Macamo, Ivalda Macicame, Raquel Matavele Chissumba, Michelle Imbach, Cacildo Magul, Leigh Anne Eller, Christina S Polyak, Victória Cumbane, Vânia Monteiro, Maria Enosse
Background: Human immunodeficiency virus type 1 (HIV-1) causes impairment of T and B cell responses, which begins during the acute phase of infection and is not completely restored by antiretroviral treatment. Regulatory T cell (Tregs) can improve ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16a1152eef80ecbd88bf7b0be4ef3956
https://doi.org/10.21203/rs.3.rs-778117/v1
https://doi.org/10.21203/rs.3.rs-778117/v1
Autor:
Lara Vojnov, Nádia Sitoe, Bindiya Meggi, Ilesh V. Jani, Ocean Tobaiwa, Timothy Bollinger, Osvaldo Loquiha, Rosa Macamo
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165163 (2016)
PLoS ONE
PLoS ONE
BACKGROUND In resource-limited countries, CD4 T-cell (CD4) testing continues to be used for determining antiretroviral therapy (ART) initiation eligibility and opportunistic infection monitoring. To support expanded access to CD4 testing, simple and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f921b49fa97520ad89594cf74f2a89
http://europepmc.org/articles/PMC5079624?pdf=render
http://europepmc.org/articles/PMC5079624?pdf=render